Isoliquiritigenin Inhibits Cell Proliferation and Induces Apoptosis in Human Hepatoma Cells

Abstract

Isoliquiritigenin (4,2′,4′-trihydroxychalcone, ISL) is a natural pigment with a simple chalcone structure. In this study, we report the ISL-induced inhibition on the growth of human hepatoma cells (Hep G2) for the first time. The cell growth inhibition achieved by ISL treatment resulted in programmed cell death in a caspase activation-dependent manner, with an IC₅₀ of 10.51 μg/mL. Outcomes of ISL treatment included the up-regulation of IκBα expression in the cytoplasm, and the decrease of NF-κB level as well as its activity in the nucleus. In addition, ISL also suppressed the expression of Bcl-X_L and c-IAP1/2 protein, the downstream target molecule of NF-κB. These results demonstrated that ISL treatment inhibited the NF-κB cell survival-signaling pathway and induced apoptotic cell death in Hep G2 cells.

Isoliquiritigenin - apoptosis - caspase - IκBα - NF-κB

References

• 1 Evan G I, Vousden K H. Proliferation, cell cycle and apoptosis in cancer.  Nature. 2001;  411 342-8
• 2 Herr I, Debatin K M. Cellular stress response and apoptosis in cancer therapy.  Blood. 2001;  98 2603-14
• 3 Dixit V, Mak T W. NF-kappaB signaling. Many roads lead to Madrid.  Cell. 2002;  111 615-9
• 4 Karin M, Cao Y, Greten F R, Li Z W. NF-kappaB in cancer: from innocent bystander to major culprit.  Nat Rev Cancer. 2002;  2 301-10
• 5 Vaya J, Belinky P A, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation.  Free Radic Biol Med. 1997;  23 302-13
• 6 Chan S C, Chang Y S, Wang J P, Chen S C, Kuo S C. Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera .  Planta Medica. 1998;  64 153-8
• 7 Tawata M, Aida K, Noguchi T, Ozaki Y, Kume S, Sasaki H, Chin M, Onaya T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice.  Eur J Pharmacol. 1992;  212 87-92
• 8 Baba M, Asano R, Takigami I, Takahashi T, Ohmura M, Okada Y, Sugimoto H, Arika T, Nishino H, Okuyama T. Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis.  Biol Pharm Bull. 2002;  25 247-50
• 9 Yamamoto S, Aizu E, Jiang H, Nakadate T, Kiyoto I, Wang J C, Kato R. The potent anti-tumor-promoting agent isoliquiritigenin.  Carcinogenesis. 1991;  12 317-23
• 10 Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, Kaneko S, Okada Y, Okuyama T, Nishino H, Tokue A. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma.  Cancer Lett. 2002;  183 23-30
• 11 Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Isoliquiritigenin inhibits the growth of prostate cancer.  Eur Urol. 2003;  43 580-6
• 12 Maggiolini M, Statti G, Vivacqua A, Gabriele S, Rago V, Loizzo M, Menichini F, Amdo S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells.  J Steroid Biochem Mol Biol. 2002;  82 315-22
• 13 Ma J, Fu N Y, Pang D B, Wu W Y, Xu A L. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells.  Planta Medica. 2001;  67 754-7
• 14 Somasundaram S, Edmund N A, Moore D T, Small G W, Shi Y Y, Orlowski R Z. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.  Cancer Res. 2002;  62 3868-75
• 15 Jiang S, Song M J, Shin E C, Lee M O, Kim S J, Park J H. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.  Hepatology. 1999;  29 101-10
• 16 Iwashita K, Kobori M, Yamaki K, Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells.  Biosci Biotechnol Biochem. 2000;  64 1813-20